Showing results (201-210 of 226) with videos related to

Sort By:
Pageof 23
Vaccine|March 26, 2016
Risk factors for measles infection in 0-7 month old children in China after the 2010 nationwide measles campaign: A multi-site case-control study, 2012-2013Chao Ma, Christopher J Gregory, Lixin Hao, et al.
Journal for Immunotherapy of Cancer|April 10, 2026
Anti-TIM-3 antibody TQB2618 in combination with penpulimab in relapsed or refractory classic Hodgkin lymphoma previously treated with PD-1/PD-L1 therapy: a multicenter, open-label, single-arm, phase Ib clinical trialHuangming Hong, Zegeng Chen, Jie Cui, et al.
Vaccine|February 16, 2016
Risk factors for measles in children aged 8 months-14 years in China after nationwide measles campaign: A multi-site case-control study, 2012-2013Lixin Hao, Chao Ma, Kathleen A Wannemuehler, et al.
Signal Transduction and Targeted Therapy|April 26, 2026
Abexinostat, a histone deacetylases inhibitor, for patients with relapsed or refractory follicular lymphoma: a multi-center, single-arm phase 2 studyLin Gui, Haifeng Liu, Huaqing Wang, et al.
Scientific Reports|July 17, 2020
Pharmacokinetics and safety of IBI301 versus rituximab in patients with CD20+ B-cell lymphoma: a multicenter, randomized, double-blind, parallel-controlled studyBo Jiang, Xiaoyan Ke, Qingyuan Zhang, et al.
The Journal of Infectious Diseases|May 28, 2009
Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in ChinaXiaofeng Liang, Shengli Bi, Weizhong Yang, et al.
Vaccine|September 5, 2009
Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccinationXiaofeng Liang, Shengli Bi, Weizhong Yang, et al.
Vaccine|August 17, 2013
Reprint of: Epidemiological serosurvey of Hepatitis B in China--declining HBV prevalence due to Hepatitis B vaccinationXiaofeng Liang, Shengli Bi, Weizhong Yang, et al.
Signal Transduction and Targeted Therapy|April 16, 2024
Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphomaHuaqing Wang, Jifeng Feng, Yanyan Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2020
Routine-Dose and High-Dose Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Exon 21-L858R Mutation: the Randomized, Phase II, INCREASE TrialXi Li, Li Zhang, Da Jiang, et al.
Pageof 23